Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000176393 | SCV000228043 | pathogenic | not provided | 2013-04-08 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001390522 | SCV001592264 | pathogenic | Qualitative or quantitative defects of dysferlin | 2021-12-22 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Gln771*) in the DYSF gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in DYSF are known to be pathogenic (PMID: 17698709, 20301480). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with DYSF-related conditions (PMID: 26000923, 32576226, 33610434, 33613410). ClinVar contains an entry for this variant (Variation ID: 94286). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. For these reasons, this variant has been classified as Pathogenic. |
Revvity Omics, |
RCV000176393 | SCV002021854 | pathogenic | not provided | 2019-08-20 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV003466982 | SCV004194210 | pathogenic | Miyoshi muscular dystrophy 1 | 2023-09-14 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV005025136 | SCV005659288 | pathogenic | Miyoshi muscular dystrophy 1; Autosomal recessive limb-girdle muscular dystrophy type 2B; Distal myopathy with anterior tibial onset | 2024-04-02 | criteria provided, single submitter | clinical testing | |
Department of Neurology, |
RCV001089587 | SCV001244906 | pathogenic | Distal myopathy with anterior tibial onset | 2019-07-01 | no assertion criteria provided | reference population |